Clinical Trial Update: Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function. [Phase 1]

View source ↗

Summary

Phase 1 trial updating renal impairment pharmacokinetics for PF-07321332 boosted with ritonavir in adults with renal impairment and in healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• PF-07321332 (nirmatrelvir)

Snippet

Sponsor: Pfizer | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2023-08-02